New section

Content Background

New section

AAMC Collaborative for Health Equity: Act, Research, Generate Evidence (CHARGE)

New section

New section

AAMC CHARGE cultivates the health equity community by advancing collaborative research, policy, and programmatic solutions to health and health care inequities.

The vision of AAMC CHARGE is an equitable and just society in which academic health centers:

  • Prioritize health equity scholarship and research across the full spectrum of scientific inquiry.
  • Partner with communities, families, and patients to develop solutions to health injustice.
  • Advocate for structural changes that address the root causes of health inequities.

AAMC CHARGE participants:

  • Share accomplishments and crowdsource opportunities for professional achievement.
  • Facilitate innovative multi-sector partnerships, collaborations, and research that contribute to the evidence base for solutions to health and health care inequities.
  • Collaborate on policy work that impacts health equity at institutional, local, state, and federal levels.

Join the CHARGE

You can join AAMC CHARGE by sending an email with your name, institution, title, and contact information. Participants will also receive our monthly newsletter, the AAMC Health Equity Research and Policy Update.

Join AAMC CHARGE


 

2020 AAMC Health Equity Call for Research: Consumer Survey of Health Care Access

Applications are open for the 2020 AAMC Health Equity Call for Research.

The Association of American Medical Colleges (AAMC) requests research proposals for access to newly available data from the AAMC Consumer Survey of Health Care Access, a nationally-representative, multiyear survey of demographic and contextual health information for over 2000 respondents. Awards will support innovative and cutting-edge studies that fit clearly within the core mission of the AAMC Collaborative for Health equity: Act, Research, Generate Evidence (CHARGE): advancing collaborative research, policy, and programmatic solutions to health and health care inequities.

Three to five research teams will receive unrestricted access to the Consumer Survey data for up to 12 months. Upon completion of studies, AAMC will provide platforms for researchers to disseminate their findings (e.g. webinars, publishing opportunities). View the full Request for Proposals (RFP).

An informational webinar was held on June 18, 2020 to discuss the application process, key dates, review criteria, and answer applicant questions. Download the slides.

All applicants must first be members of AAMC CHARGE. To join, email healthequityresearch@aamc.org with the name, title, and organization of all members of your research team. Applications close July 24, 2020 at 11:59 PM ET. 

Apply Now



Looking for past AAMC CHARGE webinars? 

Follow us on Vimeo to get notified when new recordings are posted.

AAMC HEALTH EQUITY VIDEO CHANNEL



Our Latest Policy and Advocacy Work

On May 29, 2020, the AAMC submitted comments to the Centers for Medicare and Medicaid Services (CMS) on rural maternal health disparities. In its comments, the AAMC encouraged CMS to leverage existing federal partnerships, partner with community-based stakeholders to address systemic issues, and invest in alternative care models.

On March 27, 2020, the AAMC submitted a response to a request for Stakeholder Input on Opportunities for Increased Collaboration to Advance Prevention Research from the National Institutes of Health (NIH) Office of Disease Prevention (ODP). The AAMC recommended ODP formalize its connections with nonprofit hospitals' population health efforts, and engage with other prevention and translational research programs and sites.

On February 25, 2020, the AAMC submitted comments to the Food and Drug Administration (FDA) on the development of strategic priorities for the Office of Minority Health and Health Equity (OMHHE). The AAMC recommended that the FDA and OMHHE collaborate and align research and communication practices across local, regional, and national, and minority organizations.

On February 21, 2020, the AAMC submitted comments to the National Institutes of Health (NIH) on its Proposed Research Initiative to Decrease Maternal Mortality. The AAMC urged the NIH to "identify evidence-based solutions which are translatable, effective, and can address the multiple health needs of mothers burdened by this crisis" through increased funding, alternative care models, and community engagement.

On February 3, 2020, the AAMC submitted comments to the National Institute on Minority Health and Health Disparities (NIMHD) at the National Institutes of Health on the social determinant of health (SDOH) measures proposed for inclusion in the Consensus Measures for Phenotypes and Exposures (PhenX) Toolkit. The AAMC recommended separate measures for community-level SDOH, individual-level, and health-related social needs (HRSN); measures that are accessible to, and useful for, measurement across diverse communities; and guidance concerning the ethical imperative researchers may have to refer participants who screen positive for serious HRSN and SDOH.

On October 25, 2019 the AAMC responded to a request for information from the National Center for Advancing Translational Sciences (NCATS) on improvements to the Clinical and Translational Science Awards (CTSA) Program: "The AAMC encourages NCATS to increase community engagement (CE)-focused funding to allow the CE cores to develop into “CE hubs” tasked, in part, with weaving together community- and patient-engaged efforts across the research, clinical, and training missions of their institutions."

On August 12, 2019 the AAMC submitted a comment letter to the HHS’ Office of Civil Rights that called for the withdrawal of its proposed changes to Section 1557 regulations because if the proposal is finalized it would eliminate all protections for transgender Americans as well as some for those with limited English proficiency. Section 1557 is intended to provide individuals with broad protections, ensuring that “an individual shall not . . . be excluded from participation in, be denied the benefits of, or be subject to discrimination under, any health care program or activity that is administered by an Executive Agency or any entity established under this title…”.

On August 6, 2019 the AAMC sent a letter to the Food and Drug Administration (PDF) on the agency’s request for information regarding the draft guidance Enhancing the Diversity of Clinical Trial Populations-Eligibility Criteria, Enrollment Practices, and Trial Designs. The AAMC offered comments regarding ways to broaden clinical trial eligibility requirements, improve clinical trial enrollment and retention, and use community engagement methods to increase patient participation.

On August 5, 2019 the AAMC sent a letter to the Office of Science and Technology Policy (OSTP) (PDF) to inform the development of the National Research Strategy for the President’s Roadmap to Empower Veterans and End the National Tragedy of Suicide.  AAMC offered recommendations to improve the ability to identify individual veterans and groups of veterans at greater risk of suicide and to develop public-private collaboration models to foster innovative and effective research.  

New section

New section